Development of new reverse transcriptase inhibitors

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)


Highly active anti-retroviral therapy(HAART) using two or more reverse transcriptase inhibitors(RTIs) and protease inhibitors, has dramatically improves the quality of life and survival of patients infected with human immunodeficiency virus(HIV). RTIs are categorized by their mechanism of action, into two groups, nucleoside(N) and non-nucleoside(NN) RTIs. However, resistant HIV variants against NRTIs and/or NNRTIs including multi-drug resistant, emerge after the prolonged therapy. To suppress the replication of such resistant variants, numerous anti-HIV drugs have been developed. In this review, the mechanisms of action and characters of the major drugs in clinical or under preclinical are described.

Original languageEnglish
Pages (from-to)775-779
Number of pages5
JournalNippon rinsho. Japanese journal of clinical medicine
Issue number4
Publication statusPublished - 2002 Apr
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Development of new reverse transcriptase inhibitors'. Together they form a unique fingerprint.

Cite this